Tatsis Ourania's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Feb 16, 2023
- Accession no.
- 0001209191-23-010061
- Filed
- Feb 16, 2023
- Trade date
- Feb 14, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market sales total $95.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tatsis OuraniaCIK 0001789815 | Officer (EVP, Chief Reg. & Quality Off.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2023 | Common Stock | SSaleDisposed | −71 | $295.89F2,F3 | −$21,008.19 | 65,694 | Direct | |
| Feb 14, 2023 | Common Stock | SSaleDisposed | −20 | $296.48 | −$5,929.6 | 65,674 | Direct | |
| Feb 14, 2023 | Common Stock | SSaleDisposed | −43 | $297.98F2,F4 | −$12,813.14 | 65,631 | Direct | |
| Feb 14, 2023 | Common Stock | SSaleDisposed | −135 | $299.60F2,F5 | −$40,446 | 65,496 | Direct | |
| Feb 14, 2023 | Common Stock | SSaleDisposed | −51 | $300.58F2,F6 | −$15,329.58 | 65,445 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 4 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $295.89 (range $295.36 to $296.32).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $297.98 (range $297.50 to $298.48).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $299.60 (range $299.19 to $300.16).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $300.58 (range $300.34 to $301.01).
Referenced by the price of 1 transaction in Table I.